Spotlight Pathology
2 known investors
Spotlight Pathology develops AI-based decision support software to assist pathologists in diagnosing blood cancers, integrating with existing digital pathology infrastructure to speed up diagnostic triage, automate cell counting, and improve objectivity of assessments. Its tools serve hospital pathology departments facing workforce shortages and rising diagnostic demand.
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- SPOTLIGHT PATHOLOGY LTD
- Company number
- 12435884
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 31 Jan 2020
- Registered office
- The Innovation Centre, Sci-Tech Daresbury Keckwick Lane, Daresbury, Warrington, Cheshire, WA4 4FS
- Nature of business (SIC)
- 62012 — Business and domestic software development
- Accounts
- last made up to 31 Jan 2025 · next due 31 Oct 2026
- Confirmation statement
- last made up to 30 Jan 2026 · next due 13 Feb 2027
Current officers · 5
- Richard John Byers — director, appointed 13 Oct 2021
- Martin Paul Fergie — director, appointed 31 Jan 2020
- Marcel Gehrung — director, appointed 30 Jan 2026
- Samantha Jane Perona — director, appointed 30 Jan 2026
- Andrew Edward Round — director, appointed 30 Jan 2026
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Spotlight Pathology do?
- Spotlight Pathology develops AI-based decision support software to assist pathologists in diagnosing blood cancers, integrating with existing digital pathology infrastructure to speed up diagnostic triage, automate cell counting, and improve objectivity of assessments. Its tools serve hospital pathology departments facing workforce shortages and rising diagnostic demand.
- Who are Spotlight Pathology's investors?
- Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund.